Global Epilepsy Treatment Market, By Condition (Epilepsy Drug Resistant/Intractable Epilepsy, Others), Drug (First-Generation, Second-Generation, Third-Generation), Distribution Channel (Hospitals, Clinics, Retail Pharmacies, Online Pharmacies), End Users (Hospitals, Clinics, Ambulatory Surgical Centers, Diagnostic Centers), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
The epilepsy treatment market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with the CAGR of 6.15% in the forecast period of 2021 to 2028 and is expected to reach USD 7.29 billion by 2028. The initiatives by the government and advancement in drugs and treatments across the globe are escalating the growth of epilepsy treatment market.
Epilepsy refers to chronic neurological disorder which causes constant and unfounded seizures. An individual suffering from epilepsy tends to have seizures with no explanation. These seizures could be caused by some traumatic incident or past brain injury but the real causes are still unknown. The condition is generally among children and adults but geriatric population is at more risk of acquiring the disease.
The increase in the number of accidents and brain injuries and the high rate of post-traumatic epilepsy (PTE) and post-traumatic seizure (PTS) occurrence in patients with brain injuries are the major factors driving the epilepsy treatment market. The increase in funding by government to enhance and develop effective drugs and treatments for seizures and rise in the research and development activities to provide advanced healthcare facilities accelerate the epilepsy treatment market growth. The collaboration of organizations in order to offer better treatment lines and awareness training programs to physicians and people also influence the epilepsy treatment market. Additionally, growing geriatric population, increasing epilepsy cases, rise in the awareness about the treatment options available among people and price erosion of the treatments positively affect the epilepsy treatment market. Furthermore, development of new drugs and treatment options, approval and launch of new products extend profitable opportunities to the epilepsy treatment market players in the forecast period of 2021 to 2028.
On the other hand, lack of affordability and emergence of epilepsy therapeutic methods in the developing nations are factors expected to obstruct the epilepsy treatment market. The change in prescription preference and routine of prescribing first generation anti-epileptic drugs over second generation anti-epileptic drugs are projected to challenge the epilepsy treatment market in the forecast period of 2021 to 2028.
This epilepsy treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on epilepsy treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Epilepsy Treatment Market Scope and Market Size
The epilepsy treatment market is segmented on the basis of condition, drug, distribution channel and end users. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of condition, the epilepsy treatment market is segmented into epilepsy drug resistant/intractable epilepsy and others.
- On the basis of drug, the epilepsy treatment market is segmented into first-generation, second-generation and third-generation. The first-generation drugs are further segmented into phenobarbital, carbamazepine (tegretol), valproate (depakote), ethosuximide (zarontin) and primidone (mysoline). Second-generation drugs are further segmented into lacosamide (vimpat), lamotrigine (lamictal), levetiracetam (keppra), brivaracetam (briviact) and perampanel (fycompa). Third-generation drugs are further segmented into retigabine and eslicarbazepine.
- On the basis of distribution channel, the epilepsy treatment market is segmented into hospitals, clinics, retail pharmacies and online pharmacies.
- On the basis of end users, the epilepsy treatment market is segmented into hospitals, clinics, ambulatory surgical centers and diagnostic centers.
Global Epilepsy Treatment Market Country Level Analysis
The epilepsy treatment market is analyzed and market size insights and trends are provided by country, condition, drug, distribution channel and end users as referenced above.
The countries covered in the epilepsy treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the epilepsy treatment market because of the favorable government initiatives with the purpose to enhance the healthcare system, well-developed healthcare infrastructure and rise in extensive research and development activities in the region. Asia-Pacific is estimated to grow in the forecast period of 2021-2028 due to the rise in government funding and support to improve the treatment facilities especially in the emerging economies and increasing disposable income of people in the region.
The country section of the epilepsy treatment market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The epilepsy treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for epilepsy treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the epilepsy treatment market. The data is available for historic period 2011-2019.
Competitive Landscape and Epilepsy Treatment Market Share Analysis
The epilepsy treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to epilepsy treatment market.
The major players covered in the epilepsy treatment market report are Pfizer Inc., Novartis AG, Abbott, Neurelis, GlaxoSmithKline plc, Johnson & Johnson Services Inc., Teva Pharmaceutical Industries Ltd., Sumitomo Dainippon Pharma Co. Ltd, Bausch Health, Sanofi, Takeda Pharmaceutical Company Limited, UCB S.A., Marinus Pharmaceuticals Inc., Eisai Co. Ltd, Upsher-Smith Laboratories LLC, SK BIOPHARMACEUTICALS, Vertex Pharmaceuticals Incorporated, ESTEVE, GW Pharmaceuticals plc, Zogenix Inc., Lundbeck, Supernus Pharmaceuticals Inc and DAIICHI SANKYO COMPANY LIMITED among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Epilepsy Treatment Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.